5/9/2025

Discover why Revvity remains a 'buy' despite biotech funding cuts and sector challenges.

Source: SeekingAlpha

5/9/2025

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs are […]

Source: Yahoo

5/8/2025

(Bloomberg) -- From Apple Inc. to General Motors Co., corporate America is bracing for tens of billions of dollars in damages from Trump’s trade war — and that’s before most affected goods have landed.Most Read from BloombergIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?As Trump Reshapes Housing Policy, Renters Face Rollback of RightsVail to Borrow Muni Debt to Ease Ski Resort Town Housing CrunchNYC Warns of 17% Drop in Foreign Tourists Due to Trump PoliciesLA Mayor Credits T

Source: Yahoo

5/7/2025

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Thursday, May 15, 2025 at 10:00 a.m. PT. The event will be simultaneously webcast on www.danaher.com.

Source: Yahoo

5/7/2025

Danaher (NYSE:DHR) recently affirmed a quarterly dividend of $0.32 per share, set for payout in July. Over the past month, the company's share price rose by 5%, reflecting a positive market response amid mixed broader market trends, as the Dow Jones and other indices showed varied movements tied to economic policies and earnings reports. Despite a decline in Q1 earnings and a buyback update, the dividend announcement likely added favorable sentiment towards Danaher's stock. This period's...

Source: Yahoo

5/7/2025

We came across a bullish thesis on Danaher Corporation (DHR) on Substack by Best Anchor Stocks. In this article, we will summarize the bulls’ thesis on DHR. Danaher Corporation (DHR)’s share was trading at $196.71 as of May 1st. DHR’s trailing and forward P/E were 38.12 and 25.64 respectively according to Yahoo Finance. Danaher recently reported a […]

Source: Yahoo

5/7/2025

Danaher Corp. stock outperforms competitors on strong trading day

Source: MarketWatch

5/7/2025

For Q1 2025, the Fidelity Select Health Care Portfolio returned -1.03%, underperforming the MSCI health care index. Click here to read the full commentary.

Source: SeekingAlpha

5/6/2025

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025.

Source: Yahoo

5/6/2025

Danaher Corp. stock underperforms Tuesday when compared to competitors

Source: MarketWatch

5/6/2025

Danaher Corp.'s intrinsic value shows 14% upside, but challenges like high debt & low growth reduce its investment appeal.

Source: SeekingAlpha

5/2/2025

Danaher Corp. stock rises Friday, still underperforms market

Source: MarketWatch

5/2/2025

Third Point Investors Ltd on Friday said its flagship Offshore Fund declined 3.7% in the first quarter as US tariff announcements and the prospect of a global trade war weighed on markets.The feeder...

Source: Finnhub

5/2/2025

During the First Quarter of 2025, Third Point returned -3.7% in the flagship Offshore Fund. Click here to read the full letter.

Source: SeekingAlpha

5/2/2025

Danaher delivered better-than-expected Q1 2025 results, driven by strong performance in biotechnology and molecular diagnostics. Find out why DHR stock is a Buy.

Source: SeekingAlpha

5/1/2025

We recently published an article titled Charles Akre’s and John Neff’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks with huge upside potential according to Charles Akre and John Neff. The current market environment of the […]

Source: Yahoo

5/1/2025

Danaher Corp. stock outperforms competitors despite losses on the day

Source: MarketWatch

4/30/2025

The Davenport Core Leaders Fund declined 3.48% in Q1 2025, although it did exceed its benchmark. Click here to read the full commentary.

Source: SeekingAlpha

4/29/2025

Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organizations in the gene editing, mRNA vaccine and therapeutics, viral gene therapy, and modified gene therapy spaces; today announced, a joint marketing agreement aimed at enhancing the workflow solutions for cell therapy manufacturers. The collaboration will focus on the joint promotion of the synergies achieved by combining the Aldveron Nanopla

Source: Yahoo

4/29/2025

We recently published a list of Jim Cramer Talks About Elon Musk & Discusses These 11 Stocks. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented that […]

Source: Yahoo